IHAM
Integral Health Asset Management’s Keros Therapeutics KROS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-450,000
| Closed | -$7.12M | – | 91 |
|
|
2024
Q4 | $7.12M | Buy |
450,000
+250,000
| +125% | +$3.96M | 0.61% | 51 |
|
|
2024
Q3 | $11.6M | Buy |
200,000
+115,000
| +135% | +$6.68M | 1.31% | 21 |
|
|
2024
Q2 | $3.88M | Buy |
85,000
+45,000
| +113% | +$2.06M | 0.37% | 56 |
|
|
2024
Q1 | $2.65M | Buy |
+40,000
| New | +$2.65M | 0.25% | 74 |
|
|
2023
Q3 | – | Sell |
-52,000
| Closed | -$2.09M | – | 79 |
|
|
2023
Q2 | $2.09M | Buy |
52,000
+2,000
| +4% | +$80.4K | 0.26% | 65 |
|
|
2023
Q1 | $2.14M | Sell |
50,000
-10,000
| -17% | -$427K | 0.43% | 59 |
|
|
2022
Q4 | $2.88M | Buy |
+60,000
| New | +$2.88M | 0.6% | 49 |
|
|
2022
Q2 | – | Sell |
-81,000
| Closed | -$4.41M | – | 78 |
|
|
2022
Q1 | $4.41M | Buy |
81,000
+46,000
| +131% | +$2.5M | 1.15% | 34 |
|
|
2021
Q4 | $2.05M | Buy |
+35,000
| New | +$2.05M | 0.57% | 52 |
|